Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PARAPHARMACIE MASSENA 13 NEXTYPHARM : revenue, balance sheet and financial ratios

PARAPHARMACIE MASSENA 13 NEXTYPHARM is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75013), this company of category PME shows in 2024 a net income negative of -57 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PARAPHARMACIE MASSENA 13 NEXTYPHARM (SIREN 881930499)
Kennzahl 2024 2023 2022
Umsatz N/C N/C N/C
Nettoergebnis -57 411 € -21 096 € -44 046 €
EBITDA N/C N/C N/C
Nettomarge N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, PARAPHARMACIE MASSENA 13 NEXTYPHARM records a net loss of 57 k€. This deficit will reduce equity on the balance sheet.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

-57 411 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at -67%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -129%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

-67.233%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

-128.643%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

47.9%

Entwicklung der Solvenzkennzahlen
PARAPHARMACIE MASSENA 13 NEXTYPHARM

Positionnement sectoriel

Debt ratio
-67.23 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of PARAPHARMACIE MASSENA 13 ... (-67.23) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-128.64% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Watch -14 pts über 3 Jahre

In 2024, the financial autonomy of PARAPHARMACIE MASSENA 13 ... (-128.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 33.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

33.83

Entwicklung der Liquiditätskennzahlen
PARAPHARMACIE MASSENA 13 NEXTYPHARM

Positionnement sectoriel

Liquidity ratio
33.83 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Watch -7 pts über 3 Jahre

In 2024, the liquidity ratio of PARAPHARMACIE MASSENA 13 ... (33.83) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positionnement de PARAPHARMACIE MASSENA 13 NEXTYPHARM dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PARAPHARMACIE MASSENA 13 NEXTYPHARM with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PARAPHARMACIE MASSENA 13 NEXTYPHARM

What is the revenue of PARAPHARMACIE MASSENA 13 NEXTYPHARM ?

The revenue of PARAPHARMACIE MASSENA 13 NEXTYPHARM is not publicly disclosed (confidential accounts filed with INPI).

Is PARAPHARMACIE MASSENA 13 NEXTYPHARM profitable?

PARAPHARMACIE MASSENA 13 NEXTYPHARM recorded a net loss in 2024.

Where is the headquarters of PARAPHARMACIE MASSENA 13 NEXTYPHARM ?

The headquarters of PARAPHARMACIE MASSENA 13 NEXTYPHARM is located in PARIS (75013), in the department Paris.

Where to find the tax return of PARAPHARMACIE MASSENA 13 NEXTYPHARM ?

The tax return of PARAPHARMACIE MASSENA 13 NEXTYPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PARAPHARMACIE MASSENA 13 NEXTYPHARM operate?

PARAPHARMACIE MASSENA 13 NEXTYPHARM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.